Quale tra i seguenti è un farmaco anti-VEGF?
Adalimumab
Bevacizumab
Cetuximab
Daclizumab
Ris. è "b", ovvero Bevacizumab Monoclonal AntibodyTargetIndicazioneTrastuzumabher-2/neuCancro al senoTositumomabNHL a cellule CD 20BituximabNHL a cellule CD 20BlbritumomabNHL a cellule CD 20BaclizumabIL-2R (CD-25)immunosoppressorebasiliximabIL-2R (CD-25)I mmunosoppressore AbciximabGpII/IIIaAntipiastrinicoPalivizumabProteina di fusioneRSVInfliximabTNF aRA, morbo di CrohnEtanerceptTNF aRA (rheumatoid arthritis)OfatumumabCD 20SLEBelimumabBLySSLEEpratuzumabCD 22SLEOcrelizumabCD 20SLEAdalimumabTNF aRAAlefaceptLFA-3Plaque psoriasisAlemtuzumabCD 52B cell CLLBevacizumabVEGFColorectal carcinomaCetuximabEGFRColorectal carcinomaGemtuzumabCD 33AMLEfalizumabCD 1 la chain of LFAPsoriasisOmalizumabIgEBronchial asthmaNatalizumabIntegrin-a4Multiple sclerosisDonesumabRANK ligandOsteoporosisTocilizumabIL-6RSLEPanitumumabEGFRColorectal carcinomaRanibizomabVEGFNeovascular macular degenerationNimotuzumabEGFRSquamous cell carcinoma, gliomaEculizumabC5 complement componentParoxysomal nocturnal hemoglobinuria
Anti-Cancer